Bone Marrow-Sparing IMRT in Anal Cancer Patients Undergoing Concurrent Chemo-Radiation: Results of the First Phase of a Prospective Phase II Trial.
Francesca ArcadipanePatrick SilvettiFrancesco OliveroAlessio GastinoViola De LucaMassimiliano MistrangeloPaola CassoniPatrizia RaccaElena GallioAdriana LescaChristian FiandraUmberto RicardiPierfrancesco FrancoPublished in: Cancers (2020)
18FDG-PET-guided BM-sparing IMRT was able to reduce acute HT in anal cancer patients treated with concomitant chemo-radiation. These results prompted us to conclude the second part of this prospective phase II trial.
Keyphrases
- papillary thyroid
- bone marrow
- patients undergoing
- locally advanced
- photodynamic therapy
- squamous cell
- pet ct
- positron emission tomography
- high grade
- robot assisted
- pet imaging
- liver failure
- open label
- mesenchymal stem cells
- clinical trial
- squamous cell carcinoma
- combination therapy
- radiation therapy
- lymph node metastasis
- placebo controlled
- rectal cancer
- hepatitis b virus